ISOPP/JOPP Best Paper Awards
The ISOPP/JOPP Best Paper Awards recognize articles published in the Journal of Oncology Pharmacy Practice (JOPP) for the calendar year before the current ISOPP symposia that describe an innovation in oncology pharmacy practice (Oncology Pharmacy Practice Best Paper Award) and scientific research (Oncology Pharmacy Research Best Paper Award).
ISOPP/JOPP Oncology Pharmacy Practice Best Paper Award
This award recognizes an ISOPP member who has written an article that contributes significantly to advancing the hematology/oncology pharmacy profession and describes improvements in community, hospital, or healthcare system hematology/oncology pharmacy practices. The innovations described should be applicable beyond the practice site and ideally on a global scale.
Oncology pharmacy practice is the specialty of pharmacy that incorporates the knowledge, skills, and expertise of pharmacy practice with a focus on hematology and oncology malignancies and refers to all aspects of professional practice, including administration, management, drug use control, technological services, clinical services, information processing, and new practice models.
ISOPP/JOPP Oncology Pharmacy Research Best Paper Award
This award recognizes an author who has written an important scientific article describing hematology/oncology pharmacy translational research (https://ctsi.ucla.edu/overview/mission-and-vision/the-translational-research-spectrum).
Eligible publications describe research related to hematology/oncology pharmacy practice that use the formal scientific method. Some examples include, but are not limited to studies of:
• clinical effects of cancer treatment or supportive care medications
• closed-system transfer or other safe-handling devices
• management of adverse effects
• meta-analyses
• pharmacodynamic/pharmacokinetic/pharmacogenetics
• real-world analyses of medication use
• stability/compatibility
• systematic reviews
Award
The ISOPP/JOPP Best Paper award recipients will be recognized at the ISOPP Symposia with a plaque.
Eligibility and Nomination
Nominations should be submitted on the ISOPP/JOPP Oncology Pharmacy Practice and Oncology Research Best Paper Awards Submission Form (click here for form). Self-nominations are allowed. Nominees and nominator(s) must be an ISOPP member for at least the last three (3) consecutive years. The nominated author must be the primary, lead, or senior author. A copy of the paper must be submitted with the nomination form.
Nominations are closed. The deadline for nominations for 2026 awards will be announced in the latter half of 2025.
Evaluation
The ISOPP Awards & Grants Task Force will establish a selection workgroup consisting of one member of the JOPP Advisory Board (JAB), one member of the JOPP Editorial Board, and one or more members of the ISOPP Awards & Grants Task Force. The composition of the selection workgroup and the award decision-making process must reflect ISOPP’s commitment to Equity, Diversity, and Inclusion (EDI). This includes considerations for diverse representation across geography, gender, career stage, and professional background. Submissions should be assessed with sensitivity to the unique challenges faced by authors from underrepresented or resource-limited settings, such as language barriers and limited access to research infrastructure. Evaluation should prioritize the significance, innovation, and contextual relevance of the work, recognizing its impact relative to available resources and feasibility.
Selection workgroup members must declare any real or potential conflicts of interest (COI) for each paper they are asked to evaluate by completing the ISOPP COI form before evaluating the paper.
The submissions will be judged using the approved evaluation form. The ISOPP/JOPP Awards Task Force selection workgroup will make a recommendation for award selection for each category. The selection workgroup can recommend that no award be for each category.
Note: The selection workgroup reserves the right to change the category of Best Paper Award selected by the nominator to the type that more appropriately reflects the eligibility criteria for the submitted article. The nominator will be notified if a category change is made.
Past Recipients List
2016
JOPP Best Paper Awards
Monoclonal antibodies: pharmacokinetics as a basis for new dosage regimens?
Authors: Jose R. Azanza, Belen Sadaba and Almudena Gomez-Guiu
JOPP Best Research Paper Award
The effects of a palliative care program on antidepressant use and continuing maintenance medications in near end-of-life oncology patients (the HEALED study)
Authors: Hillary Thomas, Monica Randolph and Jane Pruemer
2014
JOPP Research Award
A quantitative and qualitative method to control chemotherapeutic preparations by Fourier transform infrared–ultraviolet spectrophotometry
Authors: Florian Dziopa, Guillaume Galy, Stéphanie Bauler, Benoit Vincent, Sarah Crochon, Mamadou Lamine Tall, Fabrice Pirot, Christine Pivot
JOPP Best Practice Award
Disintegration of chemotherapy tablets for oral administration in patients with swallowing difficulties
Authors: Rivka Siden & Matthew Wolf
2012
JOPP Research Award
Key components of intravenous chemotherapy labelling: a systematic review and practice guideline
Authors: Maureen Trudeau, Esther Green, Roxanne Cosby, Flay Charbonneau, Tony Easty, Yooj Ko, Patti Marchand, U David, Nadia Berger, Sherri Hertz
JOPP Best Practice Award
Cytotoxics compounded sterile preparation control by HPLC during a 16-month assessment in a French university hospital: importance of the mixing bags step
Authors: Vincent Castagne, Helene Habert, Chadi Abbara, Eric Rudant, Laurence Bonhomme-Faivre
2010
JOPP Research Award
Use of prescription and non-prescription medications and supplements by cancer patients during chemotherapy; questionnaire validation
Authors: Marie H Hanigan, Brian L. dela Cruz, David M. Thompson, Kevin C. Farmer, Patrick J. Medina
2008
JOPP Research Award
The incidence of extravasation of vinca alkaloids supplied in syringes or minibags
Authors: Peter Gilbar, Christine Carrington
JOPP Best Practice Award
Therapeutic drug monitoring of cancer chemotherapy
Author: Lamya Alnaim
2006
JOPP Research Award
Temozolomide for malignant gliomas in British Columbia; a population based cost-effectiveness analysis
Authors: E.D. Greanya, S.C.M. Taylor, F. Hu, J. Barnett, B. Thiessen
JOPP Best Practice Award
Developing a targeted pharmacy oncology guide
Author: Dawn Annable
2004
JOPP Research Award
External contamination of vials containing cytotoxic agents supplied by pharmaceutical manufacturers
Authors: B. Favier B, L. Gilles, C. Ardiet, J.F. Latour
JOPP Best Practice Award
Development of procedures to address health and safety issues in the administration of gene therapy within the clinical setting
Authors: N.S. Stoner, R.N. Gibson, J. Edwards
2002
JOPP Research Award
Prospective evaluation of a policy of early discontinuation of antibiotics and discharge from hospital in children with cancer who develop fever
Authors: John T Wiernikowski, Ronal D. Barr, Ross Pennie
JOPP Best Practice Award
Establishing a baseline incidence of adverse drug reactions in hospitalized oncology patients
Authors: Susan Gaye Poole, Michael Joseph Dooley